rare respiratory diseases

Savara Raises $149.5M to Advance Rare Lung Therapeutic Program

LANGHORNE, Pa., November 2, 2025 — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases,...

By cGxPwire Editor
November 2, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

rare respiratory diseases

Savara Raises $149.5M to Advance Rare Lung Therapeutic Program